Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support who developed symptoms of heparin-induced thrombocytopenia (HIT) in the absence of heparin thera...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2021-01-01
|
| Col·lecció: | Case Reports in Immunology |
| Accés en línia: | http://dx.doi.org/10.1155/2021/6624682 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|